Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiemetic regimens for prevention of postoperative nausea and vomiting in gynecological day surgery with remimazolam + alfentanil
ChiCTR2100053316Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone, tropisetron and droperidol in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Weifang People's Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting (PONV). Started Nov 2021; status: recruiting.
02
Drugs
dexamethasonetropisetrondroperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2100053316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053316.